Michael J. Purcell

CIK: 0001694934

Transaction Breakdown

Open Market Buys (P)2 (13.3%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)13 (86.7%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (2)

HEPA

Hepion Pharmaceuticals, Inc.

Director

IMXI

International Money Express, Inc.

Director

Discretionary Trading P&L

Holdings

Transaction History (15 total)

HEPA
Hepion Pharmaceuticals, Inc.
Oct 23, 2026
Award(A)
Stock Options
Direct
510K shares-
IMXI
International Money Express, Inc.
Oct 1, 2026
Award(A)
Direct
1.4K shares at avg. $11.49$16K
HEPA
Hepion Pharmaceuticals, Inc.
Aug 19, 2026
Award(A)
Stock Options
Direct
299K shares-
HEPA
Hepion Pharmaceuticals, Inc.
Aug 3, 2026
Purchase(P)
Direct
2M shares at avg. $0.05$100K
IMXI
International Money Express, Inc.
Jul 16, 2026
Award(A)
Direct
10.9K shares at avg. $13.81$150K
IMXI
International Money Express, Inc.
Jul 1, 2026
Award(A)
Direct
1.1K shares at avg. $14.54$16K
HEPA
Hepion Pharmaceuticals, Inc.
Apr 21, 2026
Purchase(P)
Direct
1.3M shares at avg. $0.04$50K
IMXI
International Money Express, Inc.
Apr 1, 2026
Award(A)
Direct
989 shares at avg. $15.80$16K
IMXI
International Money Express, Inc.
Jan 1, 2026
Award(A)
Direct
1K shares at avg. $15.34$16K
IMXI
International Money Express, Inc.
Oct 1, 2025
Award(A)
Direct
1.1K shares at avg. $13.93$16K
IMXI
International Money Express, Inc.
Jul 1, 2025
Award(A)
Direct
1.5K shares at avg. $10.54$16K
IMXI
International Money Express, Inc.
Jun 20, 2025
Award(A)
Direct
14.9K shares at avg. $10.09$150K
IMXI
International Money Express, Inc.
Apr 1, 2025
Award(A)
Direct
1.2K shares at avg. $12.78$16K
IMXI
International Money Express, Inc.
Jan 1, 2025
Award(A)
Direct
750 shares at avg. $20.83$16K
IMXI
International Money Express, Inc.
Oct 1, 2024
Award(A)
Direct
889 shares at avg. $17.57$16K

		Type	Shares	Price		Ownership
Oct 23, 2026	HEPA Hepion Pharmaceuticals, Inc.	Award(A) Stock Options	510,000	-	-	Direct
Oct 1, 2026	IMXI International Money Express, Inc.	Award(A)	1,360	$11.49	$15,626	Direct
Aug 19, 2026	HEPA Hepion Pharmaceuticals, Inc.	Award(A) Stock Options	299,000	-	-	Direct
Aug 3, 2026	HEPA Hepion Pharmaceuticals, Inc.	Purchase(P)	2,000,000	$0.05	$100,000	Direct
Jul 16, 2026	IMXI International Money Express, Inc.	Award(A)	10,862	$13.81	$150,004	Direct
Jul 1, 2026	IMXI International Money Express, Inc.	Award(A)	1,075	$14.54	$15,630	Direct
Apr 21, 2026	HEPA Hepion Pharmaceuticals, Inc.	Purchase(P)	1,250,000	$0.04	$50,000	Direct
Apr 1, 2026	IMXI International Money Express, Inc.	Award(A)	989	$15.80	$15,626	Direct
Jan 1, 2026	IMXI International Money Express, Inc.	Award(A)	1,019	$15.34	$15,631	Direct
Oct 1, 2025	IMXI International Money Express, Inc.	Award(A)	1,122	$13.93	$15,629	Direct
Jul 1, 2025	IMXI International Money Express, Inc.	Award(A)	1,482	$10.54	$15,620	Direct
Jun 20, 2025	IMXI International Money Express, Inc.	Award(A)	14,867	$10.09	$150,008	Direct
Apr 1, 2025	IMXI International Money Express, Inc.	Award(A)	1,223	$12.78	$15,630	Direct
Jan 1, 2025	IMXI International Money Express, Inc.	Award(A)	750	$20.83	$15,622	Direct
Oct 1, 2024	IMXI International Money Express, Inc.	Award(A)	889	$17.57	$15,620	Direct

1-15 of 15 transactions

About Purcell Michael J.

Purcell Michael J. (SEC CIK 0001694934) files insider reports with the SEC as Director of Hepion Pharmaceuticals, Inc. (HEPA) and Director of International Money Express, Inc. (IMXI).

Signal8 holds 15 ownership filings by Purcell Michael J., all Form 4s, filed between Oct 3, 2024 and Oct 27, 2026. Those filings report 15 transactions, from Oct 1, 2024 to Oct 23, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Purcell Michael J.'s filings is in MIAMI, FL.

Recent filings by Purcell Michael J.

Oct 23, 2026: Grant or award of HEPA derivative securities (Form 4, code A).
Oct 1, 2026: Grant or award of IMXI shares (Form 4, code A).
Aug 19, 2026: Grant or award of HEPA derivative securities (Form 4, code A).
Aug 3, 2026: Open-market purchase of HEPA shares (Form 4, code P).
Jul 16, 2026: Grant or award of IMXI shares (Form 4, code A).

Other insiders filing for Hepion Pharmaceuticals, Inc. (HEPA)

Liddy James Gordon, Director
Fisher Danina, Director
Stetz Gary S., Chief Financial Officer
LoPriore Vincent S, Executive Chairman
Appajosyula Sireesh, Chief Executive Officer
LoPriore Chase, VP, Corp. Dev.

How to read Form 4 transaction codes